Tumor cavitation is associated with epidermal growth factor expression and is a predictor of poor outcome in patients with stage I non-small cell lung cancer

被引:0
|
作者
Onn, A [1 ]
Marom, E [1 ]
Isobe, T [1 ]
Choe, DH [1 ]
Correa, AM [1 ]
Putnam, JB [1 ]
Herbst, RS [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1378/chest.124.4_MeetingAbstracts.102S-a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:102S / 102S
页数:1
相关论文
共 50 条
  • [1] Tumor cavitation in stage I non-small cell lung cancer: Epidermal growth factor receptor expression and prediction of poor outcome
    Onn, A
    Choe, DH
    Herbst, RS
    Correa, AM
    Munden, RF
    Truong, MT
    Vaporciyan, AA
    Isobe, T
    Gilcrease, MZ
    Marom, EM
    RADIOLOGY, 2005, 237 (01) : 342 - 347
  • [2] Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer
    Onn, A
    Correa, AM
    Gilcrease, M
    Isobe, T
    Massarelli, E
    Bucana, CD
    O'Reilly, MS
    Hong, WK
    Fidler, IJ
    Putnam, JB
    Herbst, RS
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 136 - 143
  • [3] Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients
    Kanematsu, T
    Yano, S
    Uehara, H
    Bando, Y
    Sone, S
    ONCOLOGY RESEARCH, 2003, 13 (05) : 289 - 298
  • [4] Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor Prognosis
    Helen Han
    Jan F. Silverman
    Tibetha S. Santucci
    Robin S. Macherey
    Thomas A. dAmato
    Ming Y. Tung
    Robert J. Weyant
    Rodney J. Landreneau
    Annals of Surgical Oncology, 2001, 8 : 72 - 79
  • [5] Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis
    Han, H
    Silverman, JF
    Santucci, TS
    Macherey, RS
    dAmato, TA
    Tung, MY
    Weyant, RJ
    Landreneau, RJ
    ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (01) : 72 - 79
  • [6] Tumor Epidermal Growth Factor Receptor Genotype and Depression in Stage IV Non-Small Cell Lung Cancer
    Pirl, William F.
    Traeger, Lara
    Greer, Joseph A.
    Bemis, Heather
    Gallagher, Emily
    Lennes, Inga
    Sequist, Lecia
    Heist, Rebecca
    Temel, Jennifer S.
    ONCOLOGIST, 2011, 16 (09): : 1299 - 1306
  • [7] Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer
    Ohgino, Keiko
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hayashi, Yuichiro
    Hamamoto, Junko
    Naoki, Katsuhiko
    Arai, Daisuke
    Ishioka, Kota
    Sato, Takashi
    Terai, Hideki
    Ikemura, Shinnosuke
    Yoda, Satoshi
    Tani, Tetsuo
    Kuroda, Aoi
    Betsuyaku, Tomoko
    LUNG CANCER, 2014, 83 (01) : 90 - 96
  • [8] FDG uptake as a predictor of outcome in stage I non-small cell lung cancer.
    Viswanathan, A. K.
    Pillot, G.
    Goodgame, B.
    Yang, Z.
    Shriki, J.
    Gao, F.
    Dehdashti, F.
    Siegel, B. A.
    Govindan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 420S - 420S
  • [9] Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung Cancer
    Chen, Shuo Chueh
    Shih, Chuen Ming
    Tseng, Guan Chin
    Cheng, Wei Erh
    Chiou, Jean
    Hsiao, Michael
    Kuo, Min Liang
    Su, Jen Liang
    Chen, Chih Yi
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2011, 40 (07) : 319 - 324
  • [10] Sarcopenia Is a Novel Predictor of Poor Prognosis in Male Patients with Pathological Stage I Non-Small Cell Lung Cancer
    Tsukioka, T.
    Izumi, N.
    Chung, K.
    Komatsu, H.
    Toda, M.
    Hara, K.
    Miyamoto, H.
    Nishiyama, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2385 - S2386